Home
Sinergium Biotech

Sinergium Biotech Market Share Analysis for May 2026

Learn about the public health impact of pneumococcal vaccines in Argentina and their importance in preventing severe diseases

Industry: N/A

Domainsinergiumbiotech.com

Year Founded2011

Employees201 - 500

Annual Revenue$25M - $50M

Sinergium Biotech

Sinergium Biotech (including company regionals)

sinergiumbiotech.com

See more website traffic and engagement information

Sinergium Biotech Revenue up to May 2026 is 25M - 50M

revenue generated by Sinergium Biotech top domains

Sinergium Biotech top domains revenue over 3 years

Revenue for Sinergium Biotech top domains

sinergiumbiotech.com25M - 50M

See more with Sales Intelligence

Total visits to Sinergium Biotech's top domains

Understand Sinergium Biotech market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sinergiumbiotech.com599

See more with Sales Intelligence

Avg. visit duration in Sinergium Biotech's top domains

Analyze Sinergium Biotech engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sinergiumbiotech.com00:06:47

See more with Sales Intelligence

Avg. pageviews on Sinergium Biotech's top domains

See how Sinergium Biotech keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sinergiumbiotech.com2.72

See more with Sales Intelligence

Sinergium Biotech top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Sinergium Biotech

These are the website technologies, by industry, used by Sinergium Biotech top domains

Widget (7)

Twemoji

Social (4)

Instagram

Advertising (3)

Google Adsense

Content Management System (2)

WordPress

More Technologies

8

See all

News & Signals from Sinergium Biotech

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSINERGIUM Biotech partners with Pan American Health Organization Inc.A landmark achievement in 2025 was the agreement signed in January by the Government of Argentina, Sinergium Biotech, Pfizer, and PAHO for regional production of the PCV20 pneumococcal vaccine.

NewsPfizer Inc partners with SINERGIUM Biotech.This achievement stems from a strategic technology transfer partnership between global pharmaceutical giant Pfizer and local biotech company Sinergium Biotech.

NewsSINERGIUM Biotech is developing H5N1 vaccine candidates.The Argentinian manufacturer Sinergium Biotech, who is leading this project, has developed H5N1 vaccine candidates and is working to establish proofs-of-concept for them in preclinical models.